ClinicalTrials.Veeva

Menu

Alternate Formula Feedings in Formula Intolerant Infants

Abbott logo

Abbott

Status

Completed

Conditions

Gastrointestinal Tolerance

Treatments

Other: Infant Formula 2
Other: Infant Formula 1

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

This study assessed tolerance improvement of a formula change in healthy term infants with perceived intolerance to their current milk-based formula feeding.

Enrollment

113 patients

Sex

All

Ages

2 to 9 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infants formula-fed exclusively and experiencing symptoms of cow's milk formula intolerance.
  • Infants whose physicians had made a recommendation that the parents change the infant's feeding.
  • Full term infants at birth with a gestational age of 37 to 42 weeks.
  • Infants 2- 9 weeks of age at study entry with birth weights greater than 2500 grams.

Exclusion criteria

  • Infants with a maternal medical history which had adverse effects on the fetus, such as diabetes, tuberculosis, perinatal infections, or substance abuse.
  • Infants with evidence of cardiac, respiratory, gastrointestinal, hematological, or metabolic disease.

Trial design

113 participants in 2 patient groups

Infant Formula 1
Active Comparator group
Description:
A standard commercial milk-based infant formula
Treatment:
Other: Infant Formula 1
Infant Formula 2
Experimental group
Description:
A standard commercial soy-based infant formula.
Treatment:
Other: Infant Formula 2

Trial contacts and locations

8

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems